If there is no positive movement with share price, project or actual operation, why should directors receive bonuses, pay rises and share issues?
"Snouts in trough" comes to mind.
All shareholders need to get off their backsides and vote against any increases at the AGM.
- Forums
- ASX - By Stock
- RXL
- Ann: 2018 Annual Report & Financial Statements
Ann: 2018 Annual Report & Financial Statements, page-11
Add RXL (ASX) to my watchlist
(20min delay)
|
|||||
Last
13.5¢ |
Change
0.005(3.85%) |
Mkt cap ! $57.48M |
Open | High | Low | Value | Volume |
13.0¢ | 13.5¢ | 13.0¢ | $38.48K | 285.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 77428 | 13.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.0¢ | 214871 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 6539315 | 0.008 |
15 | 12069642 | 0.007 |
5 | 2958583 | 0.006 |
5 | 3098180 | 0.005 |
3 | 1255003 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 1924318 | 1 |
0.010 | 1406625 | 6 |
0.011 | 888479 | 5 |
0.012 | 621646 | 2 |
0.013 | 1000000 | 2 |
Last trade - 14.59pm 27/09/2024 (20 minute delay) ? |
RXL (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
Previous Video
Next Video
SPONSORED BY The Market Online